MARKHAM, ON -- (MARKET WIRE) -- October 12, 2006 -- AlphaRx Inc. (OTCBB: ALRX) announces that the Company has filed a second patent application with the U.S. Patent and Trademark Patent Office for its nanoparticle-based drug delivery platform covering several antibiotic products being developed by the Company targeted to treat life threatening infectious diseases.
